Desmodium adscendens (Sw.) DC.
In France
Absent from the French plant list of 24 June 2014. Absence from this list does not mean prohibition.
Order of 24 June 2014, Annex I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
In Belgium
Allowed in supplements in Belgium after notification (list 3).
Desmodium adscendens DC.
Parts, source text in Dutch:
bladParts, source text in French:
feuilleConditions and warnings, source text in Dutch:
Analyse moet aantonen dat de bereiding geen detecteerbare hoeveelheden dimethyltryptamine derivaten en alkaloïden van het type beta-carboline (type harmane) bevat.Conditions and warnings, source text in French:
L’analyse doit démontrer que la préparation ne contient aucune quantité détectable de dérivés de la diméthyltryptamine ni d’alcaloïdes de type bêta-carboline (type harmane).‘To be notified if in pre-dosed form’ means that a product presented in measured doses, such as capsules or tablets, must be notified to the Belgian Federal Public Service for Public Health before being marketed. Notification does not establish that a product complies with all applicable rules.
Royal Decree of 31 August 2021, annex. Belgium, Royal Decree of 31 August 2021, plant lists (annex replaced on 30 January 2024), retrieved 24 October 2026, source updated 30 January 2024.
Source: Royal Decree of 31 August 2021, annex as replaced by the Royal Decree of 12 December 2023 (Belgian Official Gazette of 30 January 2024); table read from the Gazette images and formatted by the site publisher
Declared supplements, doses and further information on the French page.